Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to V delta 1 Gamma-Delta T-Cell-Mediated Killing
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F21%3A00074678" target="_blank" >RIV/65269705:_____/21:00074678 - isvavai.cz</a>
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fimmu.2021.752646/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fimmu.2021.752646/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fimmu.2021.752646" target="_blank" >10.3389/fimmu.2021.752646</a>
Alternative languages
Result language
angličtina
Original language name
Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to V delta 1 Gamma-Delta T-Cell-Mediated Killing
Original language description
Background Endometriosis is a common gynecological disease characterized by the presence of endometrial tissue outside the uterus causing chronic inflammation, severe pain, and infertility. However, the innate immunity of gamma-delta (gamma delta) T lymphocytes in endometriosis has not been characterized. Women with endometriosis present numerous endocrine and immune dysfunctions and elevated risk for endometrial, ovarian, and breast cancers. The tyrosine kinase EphA2 is often overexpressed in cancer including endometrial carcinoma.</p> Methods We analyzed V delta 1 and V delta 2 gamma delta T cells in peripheral blood and paired peritoneal fluid samples in endometriosis patients (n = 19) and compared the counts with that of age- and sex-matched healthy donors (n = 33) using flow cytometry. V delta 1 and V delta 2 T cells isolated from healthy donors were used against KLE, RL-95, and Ishikawa endometrial tumor cells in 4 h flow cytometric cytotoxicity assays. The EphA2 blocking studies were performed using antibody, small-molecule inhibitor ALW-II-41-27, and the CRISPR/Cas9.</p> Results We determined V delta 1 T cells substantially reduced in patients' peripheral blood (p < 0.01) and peritoneal fluid (p < 0.001). No differences were found for circulating V delta 2 T cells compared with peritoneal fluid samples. We observed inherent cytotoxic reactivity of V delta 1 and V delta 2 gamma delta T lymphocytes against endometrial tumor cells. Importantly, we found reduced specific lysis of EphA2-positive cell lines KLE and RL-95 by V delta 1 T cells in the EphA2 antibody blocking studies and by the EphA2 inhibitor. Furthermore, V delta 1 T-cell-mediated killing was significantly decreased in RL-95 cell EPHA2 knockout. Finally, potent cytolytic activity exerted by V delta 1 T cells was significantly reduced in EPHA2 knockouts in renal A-498 and colon HT-29 carcinoma cell lines.</p> Conclusions We determined variable levels of V delta 1 and V delta 2 gamma delta T cells in endometriosis patients. We observed inherent cytotoxic reactivity of gamma delta T-cell subsets against endometrial cell lines. Specifically, we found that blocking of EphA2 expression resulted in significant inhibition of endometrial tumor killing mediated by V delta 1 gamma delta T cells. These results suggest that EphA2 is involved in tumor cell lysis and contributes to susceptibility to V delta 1 gamma delta T cells cytotoxic reactivity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30214 - Obstetrics and gynaecology
Result continuities
Project
<a href="/en/project/NV19-05-00410" target="_blank" >NV19-05-00410: Role of cytotoxic gamma-delta T cells implicated in therapeutic resistence and tumour recurrence in Glioblastoma Multiforme</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Immunology
ISSN
1664-3224
e-ISSN
—
Volume of the periodical
12
Issue of the periodical within the volume
OCT 7
Country of publishing house
CH - SWITZERLAND
Number of pages
12
Pages from-to
752646
UT code for WoS article
000710789400001
EID of the result in the Scopus database
2-s2.0-85117588473